The global sequencing consumables market size is calculated at US$ 8.54 billion in 2024, grew to US$ 10.49 billion in 2025, and is projected to reach around US$ 66.79 billion by 2034. The market is expanding at a CAGR of 22.84% between 2024 and 2034.
Top companies in sequencing consumables market are Swift Biosciences, Inc. (U.S.), New England Biolabs, Inc. (U.S.), Eurofins Scientific (Luxembourg), Oxford Nanopore Technologies Ltd. (UK), BGI Genomics Co., Ltd. (China), PerkinElmer, Inc. (U.S.), Macrogen Inc. (South Korea), GenScript Biotech Corporation (China), Bio-Rad Laboratories, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Illumina, Inc. (U.S.), Qiagen N.V. (Netherlands) and Thermo Fisher Scientific Inc. (U.S.).
In June 2024, the Technology Development Coordinating Center (TDCC) of the National Human Genome Research Institute (NHGRI) held the Advances in Genomic Technology Development (AGTD) symposium at The Jackson Laboratory in Farmington, Connecticut. The meeting's goal was to give NHGRI Genome Technology Program grantees an open venue to exchange and talk about important prospects and difficulties for cutting-edge genomic sequencing and synthesis technologies as well as innovative genomic methodologies.
If you have any questions, please feel free to contact us at sales@towardshealthcare.com | +1 804 441 9344